Showing results (281-290 of 2,735) with videos related to
Sort By:
Pageof 274
Expert Review of Neurotherapeutics|November 9, 2005
Oligodendrogliomas: clinical significance of 1p and 19q chromosomal deletionsAdam M Sonabend, Maciej S LesniakExpert Review of Neurotherapeutics|November 9, 2005
Risperidone in pervasive developmental disordersCraig A Erickson, Kimberly A Stigler, David J Posey, et al.Expert Review of Neurotherapeutics|December 3, 2009
Epilepsy, sex hormones and antiepileptic drugs in female patientsAlberto Verrotti, Claudia D'Egidio, Giangennaro Coppola, et al.Expert Review of Neurotherapeutics|November 12, 2009
Can peripheral leukocytes be used as Alzheimer's disease biomarkers?Kavon Rezai-Zadeh, David Gate, Christine A Szekely, et al.Expert Review of Neurotherapeutics|September 30, 2014
NF-κB and STAT3 in glioblastoma: therapeutic targets coming of ageG Kenneth Gray, Braden C McFarland, Susan E Nozell, et al.Expert Review of Neurotherapeutics|December 16, 2014
Pharmacological approaches for Alzheimer's disease: neurotransmitter as drug targetsAtish Prakash, Jaspreet Kalra, Vasudevan Mani, et al.Expert Review of Neurotherapeutics|January 13, 2015
Implications of metabotropic glutamate receptor structures for drug discovery in neurotherapeuticsAli Jazayeri, Fiona MarshallExpert Review of Neurotherapeutics|October 22, 2014
What is hydroxynorketamine and what can it bring to neurotherapeutics?Nagendra S Singh, Carlos A Zarate, Ruin Moaddel, et al.Expert Review of Neurotherapeutics|October 24, 2017
Improving diagnosis of childhood arterial ischaemic strokeMark T Mackay, Paul Monagle, Franz E BablExpert Review of Neurotherapeutics|October 13, 2017
Potential clinical utility of multiple system atrophy biomarkersKurt A JellingerPageof 274